Aims. We have described intra-general practitioner (GP) prescribing variabi
lity over time in terms of volume, cost and average item cost of prescripti
on items, within New Zealand general practice.
Methods. Longitudinal data over the financial years 1992-94 were studied fo
r two GP samples. prescription data for a regional sample of 305 GPs were o
btained for the first six months (January to June) from the New Zealand pha
rmaceutical pricing office, Health Benefits Limited. prescription data from
a second national sample of 74 GPs were obtained from the PreMeC prescript
ion analysis (PAS) database of GPs who had participated in tl;ree consecuti
ve September to December prescription analyses. The coefficient of variatio
n was used to measure the intraGP variability over time in total prescripti
on cost, volume of prescription items and average prescription item cost.
Results. The median intra-GP variability over time for the regional GP samp
le, based on reimbursement data, was 9% in total cost, 9% in total volume a
nd 5% in average item cost. The median intra-GP variability in the national
sample was very similar to the regional sample when based on reimbursement
data, but when PAS data were used the variability was 16% in total cost, 1
7% in total volume and 8% average item cost.
Conclusions. The year-on-year, intra-GP variability for cost was 9%, for vo
lume 9-10% and for average item cost 5-6%. Pharmaceutical budget estimates
should reflect year-to-year intra-GP prescribing variability of the order o
f 9%.